Back to top
more

Select Medical (SEM)

(Delayed Data from NYSE)

$34.18 USD

34.18
2,367,199

-5.00 (-12.76%)

Updated Aug 2, 2024 04:00 PM ET

After-Market: $34.18 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks.com featured highlights include: Avid Technology, Navient, Sykes Enterprises, Lake Gold and Select Medical

by Zacks Equity Research

Zacks.com featured highlights include: Avid Technology, Navient, Sykes Enterprises, Lake Gold and Select Medical

5 Stocks With High Earnings Yield to Enhance Your Portfolio

by Zacks Equity Research

Beat the coronavirus blues by investing in these high earnings yield stocks.

SEM vs. UNH: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

SEM vs. UNH: Which Stock Is the Better Value Option?

Kinjel Shah headshot

6 Valuable Price-to-Book Stocks to Buy as Recession Lurks

by Kinjel Shah

Though price-to-earnings and price-to-sales are the first choices, P/B ratio is also a convenient tool for identifying valuable stocks.

Are Investors Undervaluing Select Medical (SEM) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Select Medical Revokes Full-Year View Amid Coronavirus Blues

by Zacks Equity Research

Plagued by business uncertainty from the coronavirus outbreak, Select Medical (SEM) ditches its 2020 earnings guidance.

Sumit Singh headshot

5 Low P/CF Stocks for a Solid Portfolio Amid Coronavirus Crisis

by Sumit Singh

Investment in stocks made on diligent value analysis is usually considered one of the best practices. In value investing, investors pick stocks that are cheap but fundamentally sound.

SEM vs. HUM: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

SEM vs. HUM: Which Stock Is the Better Value Option?

Anthem (ANTM) Issues Policies for Safe Coronavirus Testing

by Zacks Equity Research

Anthem (ANTM) issues updates to ease care provider protocols regarding COVID-19 testing

Are Investors Undervaluing Select Medical (SEM) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Select Medical (SEM) Down 55.9% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Select Medical (SEM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Srijita Guha headshot

3 HMO 2019 Outperformers Likely to Retain Beat Streak in 2020

by Srijita Guha

HMO players are poised for growth on the back of higher revenues, membership growth, technological advancements and a solid capital position.

Will Select Medical Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Select Medical.

Community Health (CYH) Hits 52-Week High on Solid Q4 Results

by Zacks Equity Research

Community Health (CYH) reaches a 52-week high in Friday's trading session, backed by its strong fourth-quarter earnings performance.

What's in Store for Select Medical's (SEM) Q4 Earnings?

by Zacks Equity Research

Select Medical's (SEM) Q4 results are likely to reflect revenue growth across all its segments, increase in expenses and share buyback.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for January 31st

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Is Select Medical (SEM) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Select Medical Holdings (SEM) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (SEM) Outperforming Other Medical Stocks This Year?

Tirthankar Chakraborty headshot

New Strong Buy Stocks for January 28th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Select Medical (SEM) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Select Medical (SEM) closed at $24.15, marking a +1.09% move from the previous day.

Select Medical (SEM) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Select Medical (SEM) closed at $24.20, marking a +1.81% move from the previous day.

Select Medical (SEM) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Select Medical (SEM) closed at $23.23, marking a +0.65% move from the previous day.

Select Medical (SEM) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Select Medical (SEM) closed at $23.32, marking a +0.6% move from the previous day.

Is Select Medical (SEM) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Why Should You Retain Molina Healthcare in Your Portfolio?

by Zacks Equity Research

On the back of its restructuring initiatives and solid membership, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.